semaglutide louisiana ban lifted Medicaid might add coverage for popular obesity treatment drugs • Louisiana Illuminator FDA announces ban for compounded

Semaglutide is $499 per month and tirzepatide is $799 per month, including physician oversight

In exploratory random-effects (REML) meta-regression based on the primary pooled dataset, neither treatment duration nor ALC daily dose showed a clear association with the standardized treatment effect

Plasma folate and totlal homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function

G.JoshiD

Gastroesophageal reflux disease (GERD): Delayed gastric emptying caused by GLP-1 medications can exacerbate reflux symptoms

Because GLP1 medications can make larger volumes uncomfortable, smaller, more frequent sips throughout the day may be easier to tolerate